Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0IW8V
|
||||
Former ID |
DNC009690
|
||||
Drug Name |
L-Tryptophan-L-asparagine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529363] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H18N4O4
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC(=O)N)C(=O)O)N
|
||||
InChI |
1S/C15H18N4O4/c16-10(14(21)19-12(15(22)23)6-13(17)20)5-8-7-18-11-4-2-1-3-9(8)11/h1-4,7,10,12,18H,5-6,16H2,(H2,17,20)(H,19,21)(H,22,23)/t10-,12-/m0/s1
|
||||
InChIKey |
GRQCSEWEPIHLBI-JQWIXIFHSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of PPAR-gamma | Target Info | Inhibitor | [529363] | |
PANTHER Pathway | CCKR signaling map ST | ||||
WikiPathways | Wnt Signaling Pathway Netpath | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Differentiation of white and brown adipocyte | |||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Transcriptional Regulation of White Adipocyte Differentiation | |||||
Adipogenesis | |||||
SREBP signalling | |||||
Nuclear Receptors | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.